Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Laboratorios Farmacéuticos ROVI, S.A. has received non-binding offers for the purchase of its contract manufacturing business, as part of its strategic evaluation to enhance asset value. The proposals are subject to customary conditions including due diligence and satisfactory contract negotiations. The company will continue to assess the potential transaction’s fit, with any proceeding decision contingent on shareholder approval and regulatory authorization.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.